Search

Displaying results 6831 - 6840 of 8967 in total
  1. Drug

    Rilotumumab

    go.drugbank.com/drugs/DB11972
    Investigational

    Rilotumumab has been investigated for the treatment of Cancer, Lung Cancer, Solid Tumors, Gastric Cancer, and Prostate Cancer, among others.

  2. Drug

    SRT-2104

    go.drugbank.com/drugs/DB12186
    Investigational

    SRT2104 has been investigated for the basic science and treatment of Sepsis, PSORIASIS, Atrophy, Muscular, and Diabetes Mellitus, Type 2.

  3. Drug

    Acapatamab

    go.drugbank.com/drugs/DB18838
    Investigational

    Acapatamab is under investigation in clinical trial NCT04631601 (Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (Mcrpc)).

  4. Drug

    Zeluvalimab

    go.drugbank.com/drugs/DB18868
    Investigational

    Zeluvalimab is under investigation in clinical trial NCT04631601 (Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (Mcrpc)).

  5. Drug

    Caficrestat

    go.drugbank.com/drugs/DB15121
    Investigational

    AT-001 is under investigation in clinical trial NCT03062384 (AT-001 for Long-term Preservation of Brain Health in Aging).

  6. Drug

    Bfpet F-18

    go.drugbank.com/drugs/DB15424
    Investigational

    Bfpet F-18 is under investigation in clinical trial NCT03265431 (Evaluation of PET/MR in Patients Selected for Ablation Therapy).

  7. Drug

    3-Fluoro-L-tyrosine

    go.drugbank.com/drugs/DB04436
    Experimental

    This compound belongs to the phenylpropanoic acids. … These are compounds whose structure contain a benzene ring conjugated to a propanoic acid. 3-Fluoro-L-tyrosine targets the protein superoxide dismutase [mn], mitochondrial.

  8. Drug

    Diethyltryptamine

    go.drugbank.com/drugs/DB01460
    ExperimentalIllicit

    Diethyltryptamine (DET) is an orally active hallucinogenic agent and a substituted form of tryptamine.

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Adecatumumab

    go.drugbank.com/drugs/DB05006
    Investigational

    Adecatumumab is a recombinant human monoclonal antibody of the IgG1 subclass with a binding specificity to epithelial cell adhesion molecule (EpCAM).

  10. Drug

    Xibornol

    go.drugbank.com/drugs/DB13714
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use